Meeting
2022 ASCO Annual Meeting
Gene expression of vitamin D (VitD) pathway markers and survival in patients (Pts) with metastatic colorectal cancer (mCRC): CALGB/SWOG 80405 (Alliance).
Authors
Christine G Kohn
Beth Israel Deaconess Medical Center, Boston, MA
Christine G Kohn , Fang-Shu Ou , Chao Ma , Nicholas B Larson , Tyler J. Zemla , Chen Yuan , Donna Niedzwiecki , Bruce W. Hollis , Andrew B. Nixon , Heinz-Josef Lenz , Charles David Blanke , Richard M. Goldberg , Robert J. Mayer , Alan P. Venook , Eileen Mary O'Reilly , Jeffrey A. Meyerhardt , Kimmie Ng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3553)
DOI
10.1200/JCO.2022.40.16_suppl.3553
Abstract #
3553
Poster Bd #
347
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Polymorphisms of genes encoding for vitamin D binding protein and Wnt5a to predict outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial.
First Author: Martin D. Berger
Poster
2011 ASCO Annual Meeting
Genetic variation in vitamin D pathway and graft-versus-host disease risk after blood and marrow transplantation.
First Author: K. Robien
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Disparities and trends in biomarker testing in metastatic colorectal cancer.
First Author: Hannah Ruth Robinson
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world biomarker testing patterns among patients with metastatic colorectal cancer (mCRC) treated with later lines of therapy (LOT) in the United States (US) community oncology setting.
First Author: Arvind Katta